PMID- 30636944 OWN - NLM STAT- MEDLINE DCOM- 20190419 LR - 20220331 IS - 1598-6357 (Electronic) IS - 1011-8934 (Print) IS - 1011-8934 (Linking) VI - 34 IP - 2 DP - 2019 Jan 14 TI - Clinical Characteristics of Oral Allergy Syndrome in Children with Atopic Dermatitis and Birch Sensitization: a Single Center Study. PG - e11 LID - 10.3346/jkms.2019.34.e11 [doi] LID - e11 AB - BACKGROUND: Oral allergy syndrome (OAS) is an immunoglobulin E (IgE)-mediated hypersensitivity that occurs frequently in older children with pollen sensitization. This study focused on the clinical characteristics of OAS in children with atopic dermatitis (AD) and birch sensitization. METHOD: s: A total of 186 patients aged 2-18 years with AD and birch sensitization were enrolled in this study between January 2016 and March 2017. Their levels of serum total IgE and birch- and ragweed-specific IgE (sIgE) were measured using ImmunoCAP (Thermo Fisher Scienti fi c, Uppsala, Sweden). Information regarding causative foods and symptoms were obtained via interviews. The patients were divided into 3 groups according to their ages (group 1, 2-6 years; group 2, 7-12 years; and group 3, 13-18 years). RESULTS: Eighty-one of the 186 (43.5%) children with AD who were sensitized to birch pollen were diagnosed as having OAS. The prevalence of OAS in group 1 (the children who had AD and birch sensitization aged 2-6 years) was 36.6%. A greater predominance of men was noted in the non-OAS group (77.1%) compared to the OAS group (60.5%). Apples were the most common causative food in group 2 and 3 while kiwis were the most common cause of OAS in group 1. There was a statistically significant correlation between birch-sIgE levels and the prevalence of OAS (P = 0.000). The cut-off value was 6.77 kU(A)/L with 55.6% sensitivity and 79.0% specificity (area under the curve 0.653). CONCLUSION: In our study, the prevalence of OAS in children with AD and birch sensitization was 43.5%. Even in the preschool age group, the prevalence of OAS was considerable. Patients with high levels of birch-sIgE were more likely to have OAS. Clinicians should therefore be vigilant about OAS in patients with a high degree of sensitization to birch pollen and even young children if they have birch sensitization. FAU - Kim, Kang-In AU - Kim KI AUID- ORCID: 0000-0001-9307-5578 AD - Pediatric Allergy and Respiratory Center, Department of Pediatrics, Soonchunhyang University Hospital, Seoul, Korea. FAU - Lee, Bomi AU - Lee B AUID- ORCID: 0000-0002-5004-9916 AD - Pediatric Allergy and Respiratory Center, Department of Pediatrics, Soonchunhyang University Hospital, Seoul, Korea. FAU - Min, Taek Ki AU - Min TK AUID- ORCID: 0000-0002-5078-5622 AD - Pediatric Allergy and Respiratory Center, Department of Pediatrics, Soonchunhyang University Hospital, Seoul, Korea. FAU - Lee, Jeongho AU - Lee J AUID- ORCID: 0000-0003-4455-7540 AD - Department of Pediatrics, Soonchunhyang University Hospital, Seoul, Korea. FAU - Pyun, Bok Yang AU - Pyun BY AUID- ORCID: 0000-0002-6375-9394 AD - Pediatric Allergy and Respiratory Center, Department of Pediatrics, Soonchunhyang University Hospital, Seoul, Korea. FAU - Jeon, You Hoon AU - Jeon YH AUID- ORCID: 0000-0002-8164-7580 AD - Department of Pediatrics, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Korea. LA - eng PT - Journal Article DEP - 20190102 PL - Korea (South) TA - J Korean Med Sci JT - Journal of Korean medical science JID - 8703518 RN - 37341-29-0 (Immunoglobulin E) SB - IM MH - Actinidia/immunology MH - Adolescent MH - Ambrosia/immunology MH - Area Under Curve MH - Betula/*immunology MH - Child MH - Child, Preschool MH - Dermatitis, Atopic/complications/*diagnosis MH - Female MH - Food Hypersensitivity/complications/*diagnosis/epidemiology/prevention & control MH - Humans MH - Immunoglobulin E/blood/metabolism MH - Male MH - Malus/immunology MH - Pollen/immunology MH - Prevalence MH - ROC Curve MH - Republic of Korea/epidemiology PMC - PMC6327088 OTO - NOTNLM OT - Atopic Dermatitis OT - Birch OT - Children OT - Oral Allergy Syndrome COIS- Disclosure: The authors have no potential conflicts of interest to disclose. EDAT- 2019/01/15 06:00 MHDA- 2019/04/20 06:00 PMCR- 2019/01/14 CRDT- 2019/01/15 06:00 PHST- 2018/08/06 00:00 [received] PHST- 2018/10/17 00:00 [accepted] PHST- 2019/01/15 06:00 [entrez] PHST- 2019/01/15 06:00 [pubmed] PHST- 2019/04/20 06:00 [medline] PHST- 2019/01/14 00:00 [pmc-release] AID - 10.3346/jkms.2019.34.e11 [doi] PST - epublish SO - J Korean Med Sci. 2019 Jan 2;34(2):e11. doi: 10.3346/jkms.2019.34.e11. eCollection 2019 Jan 14.